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ABSTRACT
Cellular differentiation and development of germ
cells critically depend on a coordinated activation
and repression of specific genes. The underlying
regulation mechanisms, however, still lack a lot of
understanding. Here, we describe that both the
testis-specific transcriptional activator CREMq
(cAMP response element modulator tau) and the
repressor GCNF (germ cell nuclear factor) have an
overlapping binding site which alone is sufficient to
direct cell type-specific expression in vivo in a
heterologous promoter context. Expression of the
transgene driven by the CREM/GCNF site is detect-
able in spermatids, but not in any somatic tissue or
at any other stages during germ cell differentiation.
CREMq acts as an activator of gene transcription
whereas GCNF suppresses this activity. Both
factors compete for binding to the same DNA
response element. Effective binding of CREM
and GCNF highly depends on composition
and epigenetic modification of the binding site. We
also discovered that CREM and GCNF bind to each
other via their DNA binding domains, indicating a
complex interaction between the two factors.
There are several testis-specific target genes that
are regulated by CREM and GCNF in a reciprocal
manner, showing a similar activation pattern as
during spermatogenesis. Our data indicate that a
single common binding site for CREM and GCNF
is sufficient to specifically direct gene transcription
in a tissue-, cell type- and differentiation-specific
manner.
INTRODUCTION
Spermatogenesis is a complex process that involves the
mitotic proliferation of spermatogonial stem cells,
meiotic divisions of spermatocytes and morphological
changes of haploid spermatids to highly specialized sper-
matozoa (1). To maintain a proper cellular diﬀerentiation
and development, a deﬁned set of genes needs to be
expressed during a tightly deﬁned time window. Deletion
or mutation of just one of these critical genes within these
developmental processes could be associated with male
infertility or at least sub-fertility in animals and humans.
Deletion of the protamine genes, e.g. leads to infertility, as
these are essential for chromatin organisation in sperma-
tozoa (2). Other examples involve genes that play an
important role in energy metabolism or acrosome
reaction of spermatozoa (3–5). Mechanisms must be in
place to fulﬁl several functions at the same time: the acti-
vation of the gene in the correct cell type and the silencing
of the same gene in all other tissues. The underlying reg-
ulation for these mechanisms is largely unknown so far.
The developmental program of spermatogenesis is
regulated by several testis-speciﬁc transcription factors,
including the cAMP response element modulator tau
(CREMt) and the germ cell nuclear factor (GCNF or
NR6A1). CREMt, the testis-speciﬁc transcriptional
activator, is an alternative splice product of the CREM
gene which belongs to the cAMP-regulated family of
proteins and binds to the cAMP response element
(CRE; consensus sequence 50-TGACGTCA-30) (6,7).
CREMt is highly expressed in spermatids during
haploid germ cell development (8). Targeted gene disrup-
tion of the CREM gene leads to infertility in transgenic
animals. Here, spermatogenesis comes to a halt at the
round spermatid level (9,10). CRE or CRE-like sequences
are frequently observed in haploid expressed genes (11)
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expression in humans and mice (12–15).
The germ cell nuclear factor is a member of the nuclear
receptor superfamily of ligand-activated transcription
factors (16,17); however, a ligand for GCNF has still
not been identiﬁed. Targeted gene disruption of GCNF
leads to embryonic lethality (18). GCNF is suggested to
be a transcriptional repressor. GCNF dimers bind to a
direct repeat of the nuclear receptor half-site (50-AGGT
CA-30) with zero base pairs spacing between the half-sites
or to extended single half-sites (19–21). During embryonic
stem cell diﬀerentiation, GCNF binds and represses
pluripotency genes (22–24). Within an adult male
organism GCNF is detectable in testis, where the protein
is highly expressed in spermatids (25,26). GCNF binding
sites have been described in a limited number of
testis-speciﬁc gene promoters (19,27–29).
We previously described a dual DNA response ele-
ment for the binding of CREMt and GCNF within the
testis-speciﬁc promoter of the mitochondrial
glycerol-3-phosphate dehydrogenase (mGPDH) gene
(30,31). mGPDH contributes to the aerobic metabolism
and plays a role in capacitation of spermatozoa (32).
Targeted gene disruption of mGPDH leads to male
sub-fertility (33). Both transcription factors compete for
binding to a composite CRE/nuclear receptor binding site
(CRE/NR site). We were able to show in cell experiments
that CREMt activates gene transcription whereas GCNF
suppresses this activation (31). Interestingly, a very similar
regulation mechanism has been described for the
protamine 1 and 2 genes (34). Since this reciprocal regu-
lation pattern resembles the expression pattern of several
testis-speciﬁc target genes in haploid male germ cells, we
further characterized the CRE/NR site. In this report, we
show that the CRE/NR site has an optimal structure for
binding both factors. CREM and GCNF compete for
binding to the DNA response element and also interact
with each other via protein–protein interaction. A number
of testis-speciﬁc target genes are regulated in a similar
manner. Integration of the CRE/NR site upstream to a
heterologous promoter is suﬃcient to speciﬁcally express a
transgene in haploid germ cells. No detectable expression
in any other somatic tissue or other stages of germ cell
diﬀerentiation has been found. Our data indicate that a
small DNA stretch of only 26 nucleotides is suﬃcient to
direct testis-speciﬁc gene expression.
MATERIAL AND METHODS
Isolation and characterization of DNA sequences
Human mGPDH promoter sequence from  62 to  37
(50-ggtatcctttgtgaggtcaacaatga-30) was designed as
double-stranded oligonucleotides and ligated upstream
of the minimal rat prolactin core (PRL) promoter (from
 38 to +36) into pGL3-basic (Promega, Mannheim,
Germany), generating the construct CRE/NR-PRL-Luc.
Mutant versions of this construct were similarly designed
generating the constructs CRE/NR-4C-PRL-Luc and
CRE/NR-5T-PRL-Luc, respectively (for oligonucleotide
sequences see below). Expression plasmids for CREMt
(NM_183011) C-terminally fused with the FLAG
epitope and GCNF (AF390896) N-terminally fused with
the haemagglutinin (HA) epitope have been described
(30,31). For bacterial expression full-length CREMt
(amino acids 1 to 283) was ampliﬁed by PCR and
subcloned into pGEX-2T (Promega) generating a
glutathione S-transferase (GST) fusion protein [GST–
CREM (1–283)]. Various deletion fragments thereof
were generated in a similar way resulting in fusion
proteins GST–CREM (1–95), GST–CREM (90–220) and
GST–CREM (215–283), respectively. Full-length GCNF
was ampliﬁed by PCR and subcloned into pGEX-2T
generating the construct GST-GCNF (1–495). Various
deletion fragments thereof were generated in a similar
way resulting in fusion proteins GST-GCNF (1–150),
GST-GCNF (65–150) and GST-GCNF (140–495), respec-
tively. A sequence portion of GCNF from amino acids 65
to 160 was additionally cloned in pcDNA3.1 (Invitrogen,
Karlsruhe, Germany). Testis-speciﬁc promoter-reporter
constructs of proacrosin (from  263 to +548), ELP
( 652/+617) and SP-10 ( 408/+28) in pGL3-basic
were kind gifts of Sandra Danner (Fraunhofer Institute,
Lu ¨ beck) (35). The testis-speciﬁc promoters of t-ACE
( 114/+19) and Pdha2 ( 236/+31) were ampliﬁed by
PCR from mouse genomic DNA and subcloned into
pGL3-basic (Supplementary Figure S1). For the genera-
tion of transgenic mice, the CRE/NR-PRL sequence
portion were excised and introduced into the pWhere
vector (InvivoGen, San Diego, USA) upstream of a
LacZ gene. All constructs were conﬁrmed by DNA
sequencing. Methylated plasmids were obtained by
incubation with SssI methylase (New England Biolabs,
Frankfurt am Main, Germany) according to the
manufacturer’s recommendations and controlled by
digestion with HpaII (methylation-sensitive) and the
methylation-insensitive isoschizomer MspI. Quantitative
real-time PCR was conducted as described (36).
PCR primers were as follows: LacZ for: 50-gacaccac
agccacagacatc-30; LacZ rev: 50-cccagagagttgcccattgc-30;
b-actin for: 50-tgatggtgggaatgggtcagaa-30; b-actin rev:
50-ccaagaaggaaggctggaaaag-30.
Electrophoretic mobility shift assay
In vitro-translated CREMt-Flag and GCNF-HA were
synthesized by a transcription/translation-coupled
reticulocyte lysate system (TNT kit, Promega) according
to the manufacturer’s instructions. One microlitre of
in vitro-translated CREMt or GCNF was incubated
with 10 fmol of radioactively labelled double-stranded
wild-type oligonucleotide probe 50-ggtatcctttgtgaggtcaaca
atgacatta-30 in the presence of 1 mg of poly(dA-dT)*
poly(dA-dT) as described previously (30,31). For compe-
tition experiments, a 50-fold molar excess of double-
stranded wild-type or mutated oligonucleotides were
added to the binding reaction. Oligonucleotide sequences
are as follows (italic letters indicate the central CRE/NR
site, bold face letters indicate point mutations): wild-type,
50-ggtatcctttgtgaggtcaacaatgacatta-30; mutation 1T ! 1A,
50-ggtatcctttgagaggtcaacaatgacatta-30;4 G! 4C, 50-ggtatc
ctttgtgacgtcaacaatgacatta-30;5 G! 5T, 50-ggtatcctttg
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acaatgacatta-30;8 A! 8C, 50-ggtatcctttgtgaggtccacaatga
catta-30. For supershift experiments, 1 ml of anti-HA
(#2367, Cell Signalling Technology, Frankfurt am Main,
Germany) or anti-Flag (M2) antibodies (#F1804,
Sigma-Aldrich, Taufkirchen, Germany) were added to
the binding reaction mixtures and pre-incubated for
60min at room temperature. The shifted DNA bands
were separated on 5% polyacrylamide gels and visualized
by autoradiography on Kodak XAR ﬁlms (Kodak,
Rochester, USA).
Transient transfection experiment
Human embryonic kidney HEK293 and human
hepatocarcinoma HepG2 cells were cultured under
standard conditions in Dulbecco’s modiﬁed Eagle’s
medium plus Glutamax (Invitrogen) and 10% fetal calf
serum as described. Transient transfection experiments
were performed using a modiﬁed calcium phosphate tech-
nique (30,31,37). Typically,  7 10
5 cells per 9.6 cm
2 well
were incubated with 2mg promoter-containing pGL3
luciferase plasmid and 0.2 mg CREM or GCNF expression
plasmids. Expression plasmids have been described above.
For trichostatin A (TSA) inhibition experiments, TSA was
added to a ﬁnal concentration of 100ng/ml 24h before
the cells were harvested. Luciferase assays were carried
out in duplicates as described and normalized to the
total protein concentration of the samples, which were
determined by the Bradford method (Bio-Rad). Each
construct was tested in at least three independent
transfection experiments with two to three culture dishes
per experiment±SD.
Chromatin immunoprecipitation assay
For chromatin immunoprecipitation (ChIP) analyses, 1 mg
of CRE/NR-PRL-Luc reporter vectors, 0.1mg CREMt
plus optionally 0.1mg GCNF expression plasmids were
transfected into HepG2 cells as described (38).
Chromatin was immunoprecipitated by anti-acetylated
histone H3 (#06-599, Upstate, Hamburg, Germany),
anti-Flag (Sigma, #F1804), anti-HA (Santa Cruz,
#Y-11), anti-GCNF (gift of Uwe Borgmeyer) or irrelevant
antibodies (untreated non-speciﬁc rabbit antiserum).
Immunoprecipitated or input DNA was puriﬁed using
Qiaquick spin columns (Qiagen, Hilden, Germany)
according to the instructions of the manufacturer
ampliﬁed by quantitative PCR using pGL3forward
(50-ctagcaaaataggctgtccc-30) and pGL3reverse primers
(50-ctttatgtttttggcgtcttc-30) as described.
Protein–protein interaction
A GST-pull down was used to access the physical interac-
tion between CREM and GCNF. GST fusion proteins
(see above) were bacterially expressed in BL21
Escherichia coli according to standard protocols and
extracted in extraction buﬀer (150mM NaCl, 10mM
Na2HPO4, 1mM DTT, 0.5mM AEBSF, pH 7.4).
The expression of correctly sized proteins was monitored
by SDS–PAGE. One hundred micrograms protein
of total bacterial lysate was coupled to 150ml glutathione
sepharose 4B beads (GE Healthcare, Mu ¨ nchen, Germany)
for 1h at 4 C with constant shaking. The GST fusion
protein coupled beads were intensively washed with PD
buﬀer (100mM NaCl, 50mM Tris–HCl, 0.1mM EDTA,
0.1% BSA, 0.05% Triton X-100, 1mM DTT, 0.2mM
AEBSF, pH 7.5). In vitro-translated L-[
35S]
methionine-labelled protein (TNT kit, Promega) was
added, incubated for 2h at 4 C and afterwards washed
three times with PD buﬀer. The coupled beads were
boiled in loading buﬀer and separated by SDS–PAGE.
The gel was dried and autoradiographed.
For co-immunoprecipitations, expression plasmids of
Flag-tagged CREMt and HA-tagged GCNF were
transfected into HepG2 cells. Proteins were extracted in
lysis buﬀer (150mM NaCl, 50mM Tris–HCl, 1mM
EDTA, 1% Triton X-100, 0.5mM AEBSF, pH 7.4) and
coupled to anti-Flag M2 aﬃnity gel (Sigma) according to
the instructions of the manufacturer in the presence of 160
U DNase I. The coupled beads were washed three times
with TBS (150mM NaCl, 50mM Tris–HCl, pH 7.4) and
applied to SDS–PAGE. Western blot analysis were per-
formed using anti-Flag antibodies (Sigma, #F1804) and
anti-HA antibodies (Santa Cruz, #Y-11).
Transgenic mouse lines
A sequence portion of CRE/NR-PRL-LacZ was excised
from the plasmid CRE/NR-PRL-pWhere by PacI
digestion and gel eluted. The excised fragment contains
the sequences from  62 to  37 of the human mGPDH
gene upstream of the minimal PRL promoter ( 38/+36)
upstream of the LacZ gene. Pronucleus injection and
generating of founder animals were conducted by the
transgenic core facility at the ZMNH (University
Hamburg, Germany) according to standard protocols.
Animal experiments have been approved by local
authorities. Three founder mice were proven to carry the
transgene and two transgenic mouse lines were established
(#14 and #58). Both lines show essentially identical results
and data are shown from line #58. Transgenic mice were
identiﬁed by PCR screening of genomic DNA isolated
from tail biopsies.
Histological staining of LacZ activity in transgenic mice
For LacZ staining, transgenic animals or wild-type
littermates were killed by decapitation. Testis was
prepared, incubated in 4% paraformaldehyde for 1h at
4 C and washed in PBSmnn (150mM NaCl, 10mM
Na2HPO4, 2mM MgCl2, 0.02% NP40, 0.01%
Na-deoxycholate, pH 7.4). Tissue was incubated with
0.01U Proteinase K in PBSmnn for 2min at 37 C,
washed again with PBSmnn and incubated over night at
37 C in X-Gal staining solution [PBSmnn+5mM
K3Fe(CN)6, 5mM K4Fe(CN)6, 1mg/ml X-Gal]. Testis
tissue was again washed in PBSmnn and incubated over-
night in 4% paraformaldehyde at room temperature.
After dehydrating in ascending solutions of isopropanol
the tissue was embedded in paraﬃn. Ten micrometre
sections were dried and hydrated with decreasing concen-
trations of isopropanol, counterstained with nuclear fast
2270 Nucleic Acids Research, 2010,Vol.38, No. 7red (Roth, Karlsruhe, Germany) and analysed by micros-
copy (Zeiss, Oberkochen, Germany).
RESULTS
Reciprocal regulation of a testis-speciﬁc promoter by
CREM and GCNF
We previously described the reciprocal regulation of
the post-meiotically expressed target gene mGPDH
by CREMt and GCNF. In cell experiments, we
demonstrated a CREM-mediated activation of an
mGPDH promoter-driven reporter construct, whereas
additional co-transfection of GCNF reversed this
activity (31). These assays were limited by the low basal
activities of used promoters and it was impossible to detect
GCNF repression without preceding CREM activation.
To overcome this problem, we introduced the dual
CREM and GCNF binding site (CRE/NR site)
upstream of the minimal prolactin (PRL) promoter,
generating the construct CRE/NR-PRL-Luc. Due to the
heterologous promoter portion, this construct shows
signiﬁcant activities above background levels in HEK293
cells. Co-transfection of CREMt further activated
the CRE/NR-PRL-Luc construct, whereas additional
co-transfection of GCNF reversed the reporter activity
(Figure 1A) as observed previously. Western blot
analysis indicated no changes in CREMt expression
levels, thus GCNF-mediated down-regulation is not due
to altered CREM concentrations (not shown).
Transfection of GCNF alone dampened reporter activities
suggesting a direct interaction of GCNF with the response
element and application of trichostatin A (TSA), an inhib-
itor of histone deacetylases, partially relieves
GCNF-mediated repression (Figure 1A). To get further
insight into the repression mechanism of GCNF, we
took advantage of a GCNF-VP16 fusion protein. In this
construct, the full-length GCNF protein (including
the repressor domain) has been fused to the viral
activator domain VP16. As shown in Figure 1B, CRE/
NR-PRL-Luc reporter activities were increased after
cotransfection of GCNF-VP16 but not with VP16 alone.
This indicates that GCNF directly binds to the reporter.
CREM and GCNF modify chromatin structure
To further investigate the molecular consequences of
CREMt activation and GCNF repression we performed
ChIP analysis. After co-transfection of CREMt and
GCNF chromatin was ﬁxed by formaldehyde and
precipitated with an antibody against acetylated histone
H3 (a-acetyl H3), a marker of transcriptional open
chromatin. As expected, CREM-action leads to higher
acetylated chromatin. In contrast GCNF-action leads to
deacetylation or at least impeded acetylation of core
histone molecules (Figure 2). This demonstrates a close
correlation between chromatin accessibility and reporter
gene activities and further supports earlier observations of
correct chromatin organisation at transfected DNA tem-
plates (38,39).
Promoter occupancy increases after co-transfection
of CREM as expected. Interestingly, the amount of
promoter-bound CREM is not reduced after additional
co-transfection of GCNF. This indicates that
GCNF-mediated repression is not due to release of
CREM from DNA. Similar results have been observed
by immunoprecipitating GCNF-bound DNA (Figure 2).
Composition of the critical DNA binding site
Next, we intended to ﬁnd out which part of the dual CRE/
NR binding site is critical for binding of CREM and
GCNF, respectively. To achieve this aim, we incubated
in vitro-translated CREM or GCNF with labelled
wild-type CRE/NR site and competed with wild-type
Figure 1. Transcriptional modulatory function of CREMt and GCNF. Transient transfection experiments were performed in HEK293 cells.
(A) Expression vectors for CREMt and GCNF were co-transfected with a luciferase reporter vector carrying an mGPDH testis-speciﬁc promoter
fragment from  62 to  37 upstream of the minimal prolactin promoter (CRE/NR-PRL-Luc). Optionally, cells were stimulated with TSA.
(B) Expression vectors for the viral activator domain VP16 (VP16 only), full-length GCNF or a fusion construct of full-length GCNF and VP16
(GCNF-VP16) were co-transfected with the CRE/NR-PRL-Luc reporter. Promoter activities are presented relative to CRE/NR-PRL-Luc activities,
normalized to the total protein concentration of the cell extract±SD. Each construct was tested in ﬁve independent transfection experiments with
three culture dishes per experiment.
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iment. Under these experimental conditions, the binding
to labelled wild-type sequence is not completely blocked
by a molar excess of unlabelled sequence. Thus, we can
distinguish between better and poorer binding sites in this
competition assay. As shown in Figure 3A, mutation of
the wild-type sequence 50-tgaggtca-30 to 50-agaggtca-30
(mutation 1T ! 1A, italic letters) and mutation 4G !
4C (mutation of 50-tgaggtca-30 to 50-tgacgtca-30) are not
critical for binding to CREMt. Both mutated versions
remain suitable binding sites since they eﬃciently
compete with the labelled wild-type fragment for CREM
binding (Figure 3A, arrows). In contrast, mutations 5G !
5T, 7C ! 7T and 8A ! 8C seem to be critical for
CREM binding. All three mutated versions could not
prevent binding of CREM to the wild type sequence. To
further specify the DNA–protein complexes, we incubated
the reaction mixture with anti-Flag antibodies which super
shifted the resulting Flag-CREM-DNA complexes to
lower mobility (Figure 3A, arrowhead). Unspeciﬁc
protein–DNA complexes are indicated by asterisks.
In a similar mutation analysis, we investigated the
binding of GCNF to the CRE/NR site. As shown in
Figure 3B (arrow), mutations 1T ! 1A and 5G ! 5T
are still good binding sites for GCNF, since they eﬃciently
block binding to wild-type CRE/NR. In contrast the
mutations 4G ! 4C and 8A ! 8C are critical for appro-
priate binding of GCNF, in agreement with previous data
(19). Again, the speciﬁcity has been proven by incubation
with anti-HA antibodies which super shifted the
HA-GCNF-DNA complex (Figure 3B, arrowhead).
These data indicate that the CRE/NR site appears to be
a mixed optimum sequence for binding to both transcrip-
tion factors. There are speciﬁc nucleotides within this
motif which are essential for either CREM or GCNF
binding. In particular, the mutation 4G ! 4C remains
an appropriate binding site for CREM but not for
GCNF. In contrast, the mutation 5G ! 5T preserved
GCNF binding but lost the ability to bind CREM.
Based on this observation, we introduced the indicated
mutations into the reporter construct CRE/
NR-PRL-Luc. We expected that the variant CRE/
NR-4C-PRL-Luc remains activated by CREM but is not
repressed by GCNF any more. In contrast, we expected
that the variant CRE/NR-5T-PRL-Luc is not activated
by CREM but remains a target of GCNF repression
(compare to Figure 3A and B). However, this was
not the case. Cell experiments demonstrated that both
constructs are still activated by CREM and repressed by
GCNF (Figure 3C and D). Although the induction rates
are lower for both mutated constructs and the basal
reporter activities are higher (4C) and lower (5T)
compared to the wild-type construct.
CREM and GCNF interact physically
To investigate whether mechanisms other than direct
DNA binding to CRE/NR might be involved, we
studied whether CREM and GCNF interact physically.
We coupled bacterially expressed CREMt to glutathione
sepharose beads via a glutathione S-transferase (GST)
fusion protein and incubated the coupled beads with
radioactively labelled GCNF. As shown in Figure 4A,
GCNF binds physically to CREM. To delineate the inter-
acting domain of CREM, we divided the protein into three
overlapping protein fragments. Pull-down experiments
localized the interacting domain to the C-terminal
portion of the protein from amino acids 215 to 283. This
domain contains the DNA binding/leucine zipper domain
(bZip) of CREM.
Figure 2. CREMt and GCNF bind to the CRE/NR site. For
ChIP analysis, expression plasmids for CREMt, GCNF and the
CRE/NR-PRL-Luc reporter were co-transfected in HepG2 cells.
Chromatin was ﬁxed by formaldehyde and preserved as input control
or immunoprecipitated with antibodies against (A) acetylated histone
H3 (a-acetyl H3), (B) Flag-CREMt (a-Flag), (C) HA-GCNF (a-HA)
or (D) non-speciﬁc antibody (a-ns IgG). Immunoprecipitated DNA was
quantiﬁed by quantitative PCR and normalized to input controls of the
same samples.
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sepharose beads via a GST fusion protein and
incubated with radioactively labelled CREM. Again, we
demonstrated a protein–protein interaction between
CREM and GCNF (Figure 4B). Deletion mutation
analysis suggested that a N-terminal portion of GCNF
from amino acids 1 to 150, which contains the activator
domain AF-1 and the DNA binding domain (DBD)
of the protein preserved binding activity, whereas the
DBD alone (amino acids 65–150) is not suﬃcient for
CREM binding. However, this domain is suﬃcient to
repress CREM-mediated activation in cell experiments
suggesting that the repression activity of GCNF did
not completely depend on protein binding to CREM
(Figure 4D).
An interaction between CREM and GCNF has been
reproduced using co-immunoprecipitation (Figure 4C)
and mammalian two-hybrid assays (not shown) indicating
that CREM and GCNF interact physically via protein–
protein interactions. Since we pre-treated the co-IP
samples with DNase, we have no indication that
CREM-GCNF binding occurs via a contaminating piece
of DNA.
A common regulation mechanism for several
testis-speciﬁc gene promoters?
A reciprocal regulation of post-meiotically expressed
target genes has been described for mGPDH and the
protamine 1 and 2 genes (31,34). To test whether this is
a unique or rather common regulation mechanism, we
Figure 3. Point mutations within the CRE/NR site are critical for CREMt and GCNF binding. In vitro-translated Flag-tagged CREMt (A)o r
in vitro-translated HA-tagged GCNF (B) was incubated with the labelled CRE/NR site. For competition experiments, a 50-fold molar excess of
wild-type or mutated unlabelled CRE/NR site was added (for sequences see ‘Material and Methods’ section). Antibodies used for complex inter-
ference experiments are indicated. Speciﬁc protein–DNA complexes are indicated by arrows, non-speciﬁc complexes are indicated by asterisks, and
supershift complexes are indicated by arrowheads. (C and D) Expression plasmids for CREMt, GCNF and reporter CRE/NR-4C-PRL-Luc (carrying
the point mutation 4G ! 4C) or reporter CRE/NR-5T-PRL-Luc (carrying the point mutation 5G ! 5T) were transfected into HEK293 cells.
Promoter activities were determined as described in Figure 1.
Nucleic Acids Research,2010, Vol.38, No. 7 2273investigated several post-meiotically expressed targets
with respect to their regulation by CREM and GCNF.
For some of these target genes a CREM-mediated activa-
tion has been described [e.g. endozepine-like peptide
(ELP), proacrosin, pyruvate dehydrogenase (Pdha2),
SP-10, testis-speciﬁc angiotensin converting enzyme
(t-ACE)], whereas a binding site for GCNF has only
been described within the ELP gene promoter (12,28,40–
42). However, a reciprocal regulation of CREM and
GCNF has not been described for any of these
testis-speciﬁc promoters. As shown in Figure 5, all ﬁve
promoter–reporter constructs are activated by CREMt.
With the exception of SP-10 CREM-mediated activation
could be reversed after additional co-transfection of
GCNF. Nevertheless, reporter activities of all ﬁve
post-meiotically expressed genes could be blocked by
GCNF, although this issue is diﬃcult to address due to
the low expression rates of testis-speciﬁc promoters in per-
manent cell lines. Of note, the promoters of proacrosin,
t-ACE and mGPDH contain identical CRE/NR sites
(Supplementary Figure S1). These data suggest that the
reciprocal regulation by CREM and GCNF might be a
general principle of gene regulation for at least some
post-meiotically expressed target genes.
Functionality of CRE/NR site in vivo
To ﬁnally test whether the CRE/NR site is functionally
active in vivo, we generated a transgenic mouse line. The
CRE/NR-PRL sequence portion has been integrated
upstream of a LacZ reporter gene. This construct was
excised from plasmid DNA, injected into the pronucleus
of early mouse embryos and two transgenic mouse lines
were established. Diﬀerent tissues from transgenic animals
and wild-type littermates were prepared and RNA was
isolated, reverse transcribed and adjusted to quantitative
real-time PCR. LacZ expression levels, which are
exclusively driven by the CRE/NR-PRL promoter in
transgenic animals, were normalized to the expression
levels of the housekeeping gene b-actin. In a second nor-
malization step, LacZ expression of transgenic animals
were normalized to those of wild-type littermates. As
shown in Figure 6A, LacZ speciﬁc expression was solely
detectable from testis tissue in transgenic animals. Thus
the CRE/NR site directs gene expression in a testis-speciﬁc
manner.
We next wanted to know which particular cell type
within the testis is stained by CRE/NR-driven LacZ
expression. To this aim, we prepared testis from transgenic
animals and wild-type littermates. The tissue was pre-ﬁxed
and stained for LacZ activity. After ﬁnal ﬁxation the tissue
was embedded and analysed by microscopy. As shown in
Figure 6B–D, we detected LacZ staining solely in diﬀerent
stages of spermatid development (arrows). LacZ staining
was neither detectable in earlier developmental steps of
germ cells (arrowheads) nor in any other somatic cell
type in testis of transgenic animals (asterisks) nor in any
cell type of wild-type littermates (Figure 6E).
DISCUSSION
In this report, we describe a DNA response element which
is suﬃcient to regulate a heterologous promoter activity,
Figure 4. CREM and GCNF interact physically. (A) Fusion proteins of GST with full length and the indicated deletion mutants of CREMt were
bacterially expressed and coupled to glutathione sepharose beads. Bound beads were incubated with radioactively labelled GCNF to assay protein–
protein interactions between CREM and GCNF. (B) A fusion protein of GST with the indicated GCNF fragments were coupled to sepharose beads
and incubated with radioactively labelled CREMt.( C) Expression plasmids of Flag-tagged CREM and HA-tagged GCNF were transfected in
HepG2 cells and immunoprecipitated (IP) with anti-Flag antibodies. Immunopreciptiated fractions were analysed by western blotting (WB) using
anti-HA antibodies to detected HA-tagged GCNF and anti-Flag antibodies to detected Flag-tagged CREMt.( D) Cell experiments were performed as
described in ﬁgure legend of Figure 1A. Additionally, a GCNF deletion fragment containing solely the DNA binding domain of GCNF
(DBD-GCNF) was co-transfected demonstrating that this fragment is suﬃcient for repressor function.
2274 Nucleic Acids Research, 2010,Vol.38, No. 7resulting in a deﬁned expression in a tissue-, cell-type- and
diﬀerentiation-speciﬁc manner.
Within the testis, several fertility-relevant target genes
show a coordinated peak expression during spermatid
development in germ cells. These testis-speciﬁc target
genes contribute to a variety of physiological pathways,
such as energy metabolism, chromatin organisation or
acrosome reaction of spermatozoa. The coordinated
expression pattern during spermiogenesis thus appears to
be essential for male fertility. However, the underlying
mechanisms for peak expression (in particular
up-regulation in round spermatids and down-regulation
during spermatid elongation) are unknown. Here, we
report a short DNA response element of only 26
nucleotides (CRE/NR site) which serves as dual binding
site for the transcriptional activator CREMt and the
transcriptional repressor GCNF. Both transcription
factors are highly expressed during the developmental
time window (8,25,26). CREMt activates a CRE/
NR-driven heterologous promoter construct in cell
experiments, while additional co-transfection of GCNF
suppresses this activation (Figure 1A). Both factors
compete for binding to the same DNA response element,
thus mimicking the expression pattern during spermatid
development (Figure 3A and B) and modifying chromatin
conformation (Figure 2). Although in silico analysis did
not reveal transcription factor binding sites other than for
CREM and GCNF, we cannot completely rule out this
possibility. However, no other CRE-like binding factors
(e.g. c-fos, c-jun) or other nuclear receptors (e.g. thyroid
hormone receptor, estrogen receptor) have been described
to contribute to the promoter activity of mGPDH,
including the CRE/NR site (30,37,43).
The CRE/NR response element appears to present an
optimal setting for binding both the CRE-binding factor
CREM and the nuclear receptor GCNF. Accordingly, the
consensus sequence of the CRE/NR site diﬀers for both
factors. Speciﬁc nucleotides are critical for binding CREM
and GCNF, respectively. E.g. a point mutation in the
CRE/NR site 50-tgaggtca-30 to 50-tgacgtca-30 (mutant 4G
! 4C) converts it into the CRE consensus sequence. This
CRE consensus site appears to be an even better binding
site for CREM (Figure 3A and Supplementary Figure
2A), while GCNF could not bind to this sequence motif
any more (Figure 3B). In a reciprocal manner, the mutant
5G ! 5T remains a GCNF binding site but is defective to
bind CREM (Figure 3A and B). Based on these in vitro
binding studies it could be suggested that the 4C mutant
remains a target for CREM activation but, as GCNF
binding capacity is missing, is not being blocked by
GCNF any more. On the other hand one could expect
that the mutant 5T is not activated by CREM (due to
the lack of CREM binding capacity) but remains repressed
by GCNF in cell experiments. However, our cell experi-
ments did not conﬁrm this expectation (Figure 3C and D).
Therefore, competition of two transcription factors for
binding to the same DNA response element appears not
to be the sole mechanism of action.
Figure 5. CREMt and GCNF regulate post-meiotically expressed target genes. Expression plasmids for CREMt, GCNF and promoter constructs
for the post-meiotically expressed target genes endozepine-like peptide (ELP) (A), pyruvate dehydrogenase 2 (Pdha2) (B), proacrosin (C), SP-10
(D) or testis-speciﬁc angiotensin converting enzyme (t-ACE) (E) were co-transfected in HepG2 cells. Promoter activities are presented relative to
unstimulated luciferase activities, normalized to the total protein concentration of the cell extract±SD.
Nucleic Acids Research,2010, Vol.38, No. 7 2275Our next approach was to investigate whether CREM
and GCNF show direct protein–protein interaction. We
were indeed able to demonstrate an interaction between
the two transcription factors, and interestingly enough,
this interaction is mediated via the DBD of the proteins
(Figure 4). Interaction between members of the CRE
binding protein family and the nuclear receptor family
has been described previously; e.g. the CRE binding
protein (CREB) has been shown to interact with the
thyroid hormone receptor, thus blocking the thyroid
hormone pathway (44). On the other hand, shared DNA
response elements of two diﬀerent transcription factors
have also been described (45). We therefore conclude
that DNA binding competition represents one mode
of regulatory action, while protein–protein interaction
could be another one. Interestingly, the DBD of
GCNF is suﬃcient to repress gene transcription in cell
experiments (Figure 4D). This part of the protein has
previously been shown to be the minimal binding
domain for dimeric binding of GCNF to DNA (21,46).
Although CREM is known to prefer dimeric binding to
DNA as well, we did not observe a heterodimer consisting
of the bZip-containing protein CREM and the
nuclear receptor GCNF. ChIP and EMSA data indicate
that CREM and GCNF are able to bind DNA in
the presence of each other; however, binding appears
to be mutually exclusive (Figure 2 and Supplementary
Figure S3).
Yet another remarkable feature of the CRE/NR site
(in contrast to the CRE consensus site alone) is lacking
of a central CpG nucleotide. CpGs are almost absent
within the testis-speciﬁc promoter of mGPDH. CpG
dinucleotides are putative targets of DNA methylation
which is an epigenetic marker frequently associated with
gene silencing. Numerous testis-speciﬁc promoters
contain a low number of CpGs, whereas others promoters
contain clusters of CpGs (know as CpG islands).
The CpG-containing promoters are hypo-methylated in
testis, in contrast to their hyper-methylated status
in somatic tissues (12,47,48). Random methylation of a
CpG within a CRE site of a testis-speciﬁc promoter
would lead to a defective activation by CREM, since
CREM cannot bind and activate gene transcription
from methylated templates (Supplementary Figure S2).
Furthermore, GCNF initiates a cascade of events during
embryonic development which leads to DNA methylation
and consequently to gene silencing of target genes (24,49).
Therefore, it might be an advantage to have a CpG-free
CRE site in testis-speciﬁc promoters. This argumentation
is supported by Yasunaga and co-workers, who found
that speciﬁc 8-mers are enriched in testis-speciﬁc pro-
moters but not in somatic promoters. They discovered
that CpG-free CRE-like sites are over-represented
in testis-speciﬁc promoters, among them the sequences
of the CRE/NR site 50-tgaggtca-30 and its 50-extended
version 50-tgtgaggt-30. In contrast, the CRE consensus
and other CpG-containing CRE-like sites are enriched in
somatic promoters but under-represented in testis-speciﬁc
promoters (11). Similar results have been observed in a
recent study (50).
It is remarkable that a small DNA fragment of only
26 nucleotides is suﬃcient to speciﬁcally regulate a
heterologous promoter, resulting in gene expression in a
given developmental stage of germ cell diﬀerentiation.
First, this construct is suﬃcient to maintain appropriate
expression in spermiogenesis; and second, it blocks expres-
sion in any other somatic cell type (Figure 6). The CRE/
NR site appears to activate heterologous promoters inde-
pendent of their sequence composition. For instance, the
testis-speciﬁc promoter of mGPDH (the CRE/NR site was
originally excided from here) does not contain a TATA
box but a CAAT box, whereas the minimal prolactin
promoter (which is used for the transgenic construct)
does contain a TATA box but is deﬁcient in a CAAT
box. Several post-meiotically expressed target genes have
Figure 6. Testis-speciﬁc expression of a CRE/NR-driven transgene
in vivo. A transgenic mouse line was constructed carrying the CRE/
NR site upstream of a heterologous core promoter driving the expres-
sion of LacZ. (A) Several tissues from transgene-carrying and
non-transgene-carrying mice were prepared and LacZ expression was
studied by quantitative PCR. LacZ expression levels were normalized
to b-actin expression levels. In a second normalization step, the
normalized LacZ expression of transgenes were normalized to those
of wild type littermates in a given tissue. Expression levels were
expressed relative to testis expression rates. Data are shown from one
representative pair of transgene-carrying versus non-transgene-carrying
siblings and analyses are performed in triplicates±SD. Testis of
transgene-carrying mice (B–D) and wild-type littermate (E) were
prepared and LacZ activity was monitored in histological sections.
LacZ activity was detectable in spermatids (arrows) but neither in
earlier steps of germ cell development (arrowheads) nor in other
somatic tissues (asterisks). LacZ activity was also absent in
non-transgene-carrying wild type littermates (E). Sections were
counterstained with nuclear fast red and bars represent 50mm.
2276 Nucleic Acids Research, 2010,Vol.38, No. 7been described to contain CRE-like sequences and a
number of these gene promoters are regulated by
CREM and GCNF in a reciprocal manner (Figure 5).
It has been long known that surprisingly small promoter
fragments of  100 nucleotides are suﬃcient to regulate a
transgene, resulting in haploid gene expression in
transgenic animals. For protamine 1, a sequence portion
from  150 to  37 is suﬃcient for appropriate localisation.
This sequence portion contains both a CRE site and a
GCNF binding site (34,51) (Supplementary Figure S1).
A second example is the testis-speciﬁc promoter of
t-ACE which is also reciprocally regulated by CREM
and GCNF (Figure 5E). Here, a sequence portion from
 91 to +17 is suﬃcient for testis-speciﬁc expression.
Interestingly, the sequence portion from  55 to  48 in
the same promoter is 100% identical to the CRE/NR
site described in this report (40,52) (Supplementary
ﬁgure 1). Other examples are the promoters of SP-10,
pyruvate dehydrogenase 2, lactate dehydrogenase c and
b1,4-galactosyltransferase-I (12,15,41,48,53). These
transgenic mouse models do show speciﬁc expression in
testis but are devoid of reporter gene expression in any
othersomatictissue.Maybethetransgeneservesasaninsu-
lator in somatic tissues by tethering the transgene to the
nuclear matrix (54). However, to our knowledge it has not
been reported that both the testis-speciﬁc expression and
the lack of expression in somatic tissues was mediated by
only one response element in a heterologous context.
Sequence analyses suggested that the position of the
CRE/NR site relative to the transcriptional start site
(TSS) might be critical for appropriate function. All the
CRE-like sequences mentioned above are located at
 50±20 nucleotides relative to TSS. This observation
is supported by recent ﬁndings by Nozaki and co-workers,
who examined EGFP-tagged promoter constructs in
testis, using an in vivo electroporation method for tran-
sient transfection. Nozaki and co-workers (14) described
that not only the position relative to the TSS but also the
orientation of the CRE-like sequence appears to be impor-
tant for CREM-mediated activation. The positional eﬀect
is further supported by the above mentioned in silico data.
However, eﬀects mediated by orientation appear to be
unlikely since the reverse CRE/NR sequence 50-tgacctca-30
is also enriched in testis-speciﬁc promoters (11).
Conclusively, we suggest that the CRE/NR site repre-
sents a key compound for testis-speciﬁc expression. The
site is a target for a coordinated action of CREMt and
GCNF. The activity of these two factors leads to a tissue-,
cell-type- and diﬀerentiation-speciﬁc expression.
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Supplementary Data are available at NAR Online.
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